SEC EDGARAUG 311 min read$EL

La Lande Rashida sold $802K of EL

La Lande Rashida (Exec VP & General Counsel) sold 7,766 shares of ESTEE LAUDER COMPANIES INC (EL) at $103.32 ($0.80M total) on 2026-08-28.

Original reporting

SEC EDGAR · La Lande Rashida

Published Aug 31, 2026, 8:07 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Aug 31, 2026, 8:27 PM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

AlphAI market briefInsider activity

Primary signal

$EL

Neutral

medium confidence

Mentioned

$EL

Relevance

5/10

AlphAI data visualization · based on SEC EDGAR

Decision brief

The 30-second read

$ELNeutralLow

Why it matters

The sale reduces insider ownership to zero, which may be noted by analysts but unlikely to move the stock significantly.

Market read

Primary insider sale filing; modest size limits market impact.

What to watch

Potential tax-driven sale or diversification; no indication of material insider concern.

Relevance 5/10Novelty 5/10Timing: post-market 2026-08-28

Background

SEC Form 4 filing discloses insider transactions; required for officers and directors.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$ELNeutralMedium confidence

Context

Exec VP & General Counsel La Lande Rashida sold 7,766 shares for $802,383, reducing holdings to zero.

Expected impact

Potential short-term pressure on EL stock, likely limited to a few basis points.

Evidence & confidence

Form 4 filing is primary source; $0.8M sale is small for a large cap, so impact is modest.

Market effects

Sector

Minimal effect on cosmetics sector; insider activity typical.

Regional

U.S. market only; no broader regional impact.

Global

Low global relevance.

Counterpoint

What could challenge this read

Sale could be routine portfolio rebalancing, not a negative signal.

Key entities

Company
Estee Lauder Companies Inc.
US-listed cosmetics giant (ticker EL).
Insider
La Lande Rashida
Executive Vice President & General Counsel.

Read at source ← All news

SEP 15

$ELLow

FRIBOURG PAUL J sold $10.0M of EL (indirect holdings)

FRIBOURG PAUL J sold 103,000 indirectly-held shares of ESTEE LAUDER COMPANIES INC (EL) at an average of $97.56 ($96.78–$98.79, $10.05M total) across 4 trades over 2026-09-11 to 2026-09-14.

SEC EDGAR1 min

SEP 15

$ELMed

Estee Lauder outlook revised to stable by S&P on deleveraging

S&P Global Ratings revised Estee Lauder's outlook to stable from negative, citing improved operating results and credit metrics. The agency expects adjusted leverage to fall to 1.9x by fiscal 2027, with mid-single-digit revenue growth and expanded EBITDA margins. Cash flows are projected to decline due to restructuring and investments, but the company plans to use cash balances for debt repayment.

investing.com2 min

AUG 28

$ELHighAI 8/10

Estée Lauder (EL)’s China Bet Just Paid Off. Its Makeup Business Still Hasn’t Caught Up

Estée Lauder (EL) reported Q4 net sales of $3.63B, up 6.3%, driven by luxury fragrance and skincare. It forecasted fiscal 2027 adjusted EPS of $3.10-$3.35, above estimates, sending shares up 11% premarket. However, makeup sales were flat, and hair care dropped 1%. The company also reported a $38M tariff-refund benefit and a net loss of $116M, down from $546M a year earlier.

yahoo.com2 min

AUG 28

$ELMedAI 8/10

Estee Lauder vs Nike: One Turnaround Just Proved Itself, the Other Keeps Slipping

Estee Lauder (EL) reported four consecutive earnings beats, raising its fiscal 2027 EPS guidance to $3.10-$3.35. Nike (NKE) guided revenue down, with Greater China down 12% and Converse down 32%. EL's stock rose 10.46% post-earnings, while NKE's turnaround timeline extends. EL's forward P/E is near 32, with a 1.3% yield. NKE offers a 4.3% yield but faces declining revenue.

aol.com3 min

AUG 27

$MRNAHighAI 8/10

3 Stocks Soared, 3 Stocks Slumped

Moderna (MRNA) surged 176.97% to $174.38 after reporting positive trial results for a cancer therapy with Merck (MRK). Estee Lauder (EL) rose 16% to $98.01 with revenue up 6.5% Y/Y. MicroStrategy (MSTR) gained 12.68% as Bitcoin prices rose. Nebius (NBIS) fell 10% after a $4.5B convertible note offering. Seagate (STX) dropped 8% to $832.56.

baystreet.ca2 min